A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma

BACKGROUND: Targeting PLK1 has recently been proven as a viable therapeutic strategy against oesophageal squamous cell carcinom (ESCC). Therefore, this study aimed to explore whether the PLK1 inhibitor BI2536 is able to sensitize ESCC cells to cisplatin (DDP) and determine the underlying mechanisms....

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Mengjiao, Wang, Yan, Yang, Di, Gong, Ying, Rao, Feng, Liu, Rui, Danna, Yeerken, Li, Jinting, Fan, Jiawen, Chen, Jie, Zhang, Weimin, Zhan, Qimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442225/
https://www.ncbi.nlm.nih.gov/pubmed/30876762
http://dx.doi.org/10.1016/j.ebiom.2019.02.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442225/
https://www.ncbi.nlm.nih.gov/pubmed/30876762
http://dx.doi.org/10.1016/j.ebiom.2019.02.012

Ejemplares similares